Vertex Pharmaceuticals Inc. buy JPMorgan Chase & Co.
Start price
01.02.24
/
50%
€400.30
Target price
01.02.25
€404.41
Performance (%)
-1.92%
Price
10.05.24
€392.60
Summary
This prediction is currently active. With a performance of -1.92%, the BUY prediction for Vertex Pharmaceuticals Inc. by JPMorgan_Chase___Co_ is down slightly. This prediction currently runs until 01.02.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Vertex Pharmaceuticals Inc. | 5.368% | 5.368% |
iShares Core DAX® | 4.094% | 3.543% |
iShares Nasdaq 100 | 1.424% | 0.512% |
iShares Nikkei 225® | -1.572% | -4.633% |
iShares S&P 500 | 1.822% | 0.963% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at JPMorgan Chase & Co. from $390.00 to $438.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat